NCT00364468View on ClinicalTrials.gov

Dose Finding Study of KRN125 (Pegfilgrastim) for Treatment of Neutropenic Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

107

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Neutropenia
Interventions
DRUG

pegfilgrastim

Trial Locations (6)

Unknown

Tokai region, Aichi

Kyusyu region, Fukuoka, Nagasaki

Kanto region, Gunma, Saitama, Tokyo, Kanagawa

Hokkaido region, Hokkaido

Kinki region, Kyoto, Mie, Shiga

Tohoku region, Miyagi

All Listed Sponsors
lead

Kyowa Kirin Co., Ltd.

INDUSTRY

NCT00364468 - Dose Finding Study of KRN125 (Pegfilgrastim) for Treatment of Neutropenic Patients | Biotech Hunter | Biotech Hunter